Plasma brain‐derived tau (BD‐tau), a marker for Alzheimer's disease (AD) and neuronal and axonal damage,23 showed good performance in predicting outcomes in stroke and traumatic brain injury,24, 25 suggesting a plausible importance in prognosis prediction in neurological disorders. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.